| Inflammatory Bowel Disease |
1 |
1 |
| COVID-19 |
0 |
0.99 |
| Michigan |
0 |
0.56 |
| Abdominal Pain |
0 |
0.48 |
| Abdomen |
0 |
0.28 |
| Pain |
0 |
0.28 |
| Remission |
0 |
0.28 |
| Severe Acute Respiratory Syndrome |
0 |
0.28 |
| Small Intestinal Bacterial Overgrowth |
0 |
0.24 |
| Adherence |
0 |
0.14 |
| Bacterial Overgrowth Syndrome |
0 |
0.14 |
| Board Certification |
0 |
0.14 |
| Clinical Guidelines |
0 |
0.14 |
| Colitis |
0 |
0.14 |
| Corticosteroids |
0 |
0.14 |
| Emesis |
0 |
0.14 |
| Epidemiology |
0 |
0.14 |
| Health Care Quality, Access, and Evaluation |
0 |
0.14 |
| Nausea |
0 |
0.14 |
| New York |
0 |
0.14 |
| Small Intestine |
0 |
0.14 |
| Tumor |
0 |
0.14 |
| Ventilator |
0 |
0.14 |
| Diarrhea |
0 |
0.1 |
| Pain Management |
0 |
0.09 |
| Multiple Sclerosis |
0 |
0.08 |
| Acute Respiratory Distress Syndrome |
0 |
0.05 |
| Abdominal Infection |
0 |
0.04 |
| Ulcerative Colitis |
0 |
0.04 |
| Biologic Therapy |
0 |
0.03 |
| Crohn Disease |
0 |
0.03 |
| Irritable Bowel Syndrome |
0 |
0.03 |
| Mechanical Ventilation |
0 |
0.03 |
| Social Determinants of Health |
0 |
0.03 |